Literature DB >> 1627975

Multiple sclerosis and ECT: possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients.

G Mattingly1, K Baker, C F Zorumski, G S Figiel.   

Abstract

Electroconvulsive therapy (ECT) has been used effectively in treating depressed patients with multiple sclerosis (MS). However, several reports have observed that some patients with MS may suffer neurological deterioration during ECT. The authors describe the outcomes of 3 depressed patients with MS who were treated with ECT. Consistent with previous works, ECT effectively treated the psychiatric symptoms; however, 1 patient deteriorated neurologically during ECT. The brain MRI findings and clinical courses of all 3 patients are discussed, along with the possible value of gadolinium-contrast MRI scans for identifying high-risk patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1627975     DOI: 10.1176/jnp.4.2.145

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  8 in total

1.  Treatment of mood disorders in multiple sclerosis.

Authors:  Luis Pintor Pérez; Roberto Sánchez González; Eva Baillés Lázaro
Journal:  Curr Treat Options Neurol       Date:  2015-01       Impact factor: 3.598

2.  Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Authors:  Ida S Haussleiter; Martin Brüne; Georg Juckel
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

Review 3.  Catatonia after cerebral hypoxia: do the usual treatments apply?

Authors:  Davin K Quinn; Christopher C Abbott
Journal:  Psychosomatics       Date:  2014-03-27       Impact factor: 2.386

Review 4.  The link between multiple sclerosis and depression.

Authors:  Anthony Feinstein; Sandra Magalhaes; Jean-Francois Richard; Blair Audet; Craig Moore
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

Review 5.  Electroconvulsive Therapy in Multiple Sclerosis.

Authors:  Katie Steen; Puneet Narang; Steven Lippmann
Journal:  Innov Clin Neurosci       Date:  2015 Jul-Aug

6.  Ketamine Therapy for Treatment-resistant Depression in a Patient with Multiple Sclerosis: A Case Report.

Authors:  Michael M Messer; Irina V Haller
Journal:  Innov Clin Neurosci       Date:  2017-02-01

7.  Suicide in Neurologic Illness.

Authors:  David B. Arciniegas; C. Alan Anderson
Journal:  Curr Treat Options Neurol       Date:  2002-11       Impact factor: 3.598

8.  Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations.

Authors:  Maria Skokou; Evanthia Soubasi; Philippos Gourzis
Journal:  ISRN Neurol       Date:  2012-10-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.